Nexavar Maintenance Improves Survival for Patients with AML Subset 🔗 Access full article via CureTodayPatients with a subset of acute myeloid leukemia may have improved survival rates and lower risk of relapse with Nexavar maintenance. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
